Journal of Medicinal Chemistry
Article
(8) Zeng, L.; Zhou, M. Bromodomain: an acetyl-lysine binding
domain. FEBS Lett. 2002, 513, 124−128.
Savitski, M. M.; Huthmacher, C.; Gudgin, E.; Lugo, D.; Beinke, S.;
Chapman, T. D.; Roberts, E. J.; Soden, P. E.; Auger, K. R.; Mirguet,
O.; Doehner, K.; Delwel, R.; Burnett, A. K.; Jeffrey, P.; Drewes, G.;
Lee, K.; Huntly, B. J. P.; Kouzarides, T. Inhibition of BET recruitment
to chromatin as an effective treatment for MLL-fusion leukaemia.
Nature 2011, 478, 529−533.
(26) Hay, D.; Fedorov, O.; Filippakopoulos, P.; Martin, S.; Philpott,
M.; Picaud, S.; Hewings, D. S.; Uttakar, S.; Heightman, T. D.; Conway,
S. J.; Knapp, S.; Brennan, P. E. The design and synthesis of 5 and 6-
isoxazolylbenzimidazoles as selective inhibitors of the BET bromodo-
mains. Med. Chem. Commun. 2013, 4, 140−144.
(27) Fish, P. V.; Filippakopoulos, P.; Bish, G.; Brennan, P. E.;
Bunnage, M. E.; Cook, A. S.; Federov, O.; Gerstenberger, B. S.; Jones,
H.; Knapp, S.; Marsden, B.; Nocka, K.; Owen, D. R.; Philpott, M.;
Picaud, S.; Primiano, M. J.; Ralph, M. J.; Sciammetta, N.; Trzupek, J.
D. Identification of a chemical probe for bromo and extra C-terminal
bromodomain inhibition through optimization of a fragment-derived
hit. J. Med. Chem. 2012, 55, 9831−9837.
(28) Chung, C.-W.; Dean, A. W.; Woolven, J. M.; Bamborough, P.
Fragment-based discovery of bromodomain inhibitors part 1: inhibitor
binding modes and implications for lead discovery. J. Med. Chem.
2012, 55, 576−586.
(9) Filippakopoulos, P.; Knapp, S. The bromodomain interaction
module. FEBS Lett. 2012, 586, 2692−2704.
(10) Filippakopoulos, P.; Picaud, S.; Mangos, M.; Keates, T.;
Lambert, J.-P.; Barsyte-Lovejoy, D.; Felletar, I.; Volkmer, R.; Muller,
S.; Pawson, T.; Gingras, A.-C.; Arrowsmith, C. H.; Knapp, S. Histone
recognition and large-scale structural analysis of the human
bromodomain family. Cell 2012, 149, 214−231.
(11) Muller, S.; Filippakopoulos, P.; Knapp, S. Bromodomains as
therapeutic targets. Expert Rev. Mol. Med. 2011, 13, e29.
(12) Prinjha, R. K.; Witherington, J.; Lee, K. Place your BETs: the
therapeutic potential of bromodomains. Trends Pharmacol. Sci. 2012,
33, 146−153.
(13) Chung, C.-W.; Tough, D. F. Bromodomains: a new target class
for small molecule drug discovery. Drug Discovery Today: Ther.
Strategies 2012, 9, e111−e120.
(14) Chung, C.-W. Small molecule bromodomain inhibitors:
extending the druggable genome. Prog. Med. Chem. 2012, 51, 1−55.
(15) Brennan, P.; Filippakopoulos, P.; Knapp, S. The therapeutic
potential of acetyl-lysine and methyl-lysine effector domains. Drug
Discovery Today: Ther. Strategies 2012, 9, e101−e110.
(16) Hewings, D. S.; Rooney, T. P. C.; Jennings, L. E.; Hay, D. A.;
Schofield, C. J.; Brennan, P. E.; Knapp, S.; Conway, S. J. Progress in
the development and application of small molecule inhibitors of
bromodomain-acetyl-lysine interactions. J. Med. Chem. 2012, 55,
9393−9413.
(17) Filippakopoulos, P.; Qi, J.; Picaud, S.; Shen, Y.; Smith, W. B.;
Fedorov, O.; Morse, E. M.; Keates, T.; Hickman, T. T.; Felletar, I.;
Philpott, M.; Munro, S.; McKeown, M. R.; Wang, Y.; Christie, A. L.;
West, N.; Cameron, M. J.; Schwartz, B.; Heightman, T. D.; La
Thangue, N.; French, C. A.; Wiest, O.; Kung, A. L.; Knapp, S.;
Bradner, J. E. Selective inhibition of BET bromodomains. Nature
2010, 468, 1067−1073.
(29) Bamborough, P.; Diallo, H.; Goodacre, J. D.; Gordon, L.; Lewis,
A.; Seal, J. T.; Wilson, D. M.; Woodrow, M. D.; Chung, C.-W.
Fragment-based discovery of bromodomain inhibitors part 2:
optimization of phenylisoxazole sulfonamides. J. Med. Chem. 2012,
55, 587−596.
(30) Philpott, M.; Yang, J.; Tumber, T.; Fedorov, O.; Uttarkar, S.;
Filippakopoulos, P.; Picaud, S.; Keates, T.; Felletar, I.; Ciulli, A.;
Knapp, S.; Heightman, T. D. Bromodomain-peptide displacement
assays for interactome mapping and inhibitor discovery. Mol. BioSyst.
2011, 7, 2899−2908.
(31) Dunitz, J. D. The entropic cost of bound water in crystals and
biomolecules. Science 1994, 264, 670.
(32) Ellermann, M.; Jakob-Roetne, R.; Lerner, C.; Borroni, E.;
Schlatter, D.; Roth, D.; Ehler, A.; Rudolph, M. G.; Diederich, F.
Molecular recognition at the active site of catechol-o-methyltransfer-
ase: energetically favorable replacement of a water molecule imported
by a bisubstrate inhibitor. Angew. Chem., Int. Ed. 2009, 48, 9092−9096.
(33) Kohler, P. C.; Ritschel, T.; Schweizer, W. B.; Klebe, G.;
Diederich, F. High-affinity inhibitors of tRNA-guanine transglycosylase
replacing the function of a structural water cluster. Chem.Eur. J.
2009, 15, 10809−10817.
(18) Nicodeme, E.; Jeffrey, K. L.; Schaefer, U.; Beinke, S.; Dewell, S.;
Chung, C.-W.; Chandwani, R.; Marazzi, I.; Wilson, P.; Coste, H.;
White, J.; Kirilovsky, J.; Rice, C. M.; Lora, J. M.; Prinjha, R. K.; Lee, K.;
Tarakhovsky, A. Suppression of inflammation by a synthetic histone
mimic. Nature 2010, 468, 1119−1123.
(19) Adachi, K.; Hikawa, H.; Hamada, M.; Endoch, J.-I.; Ishibichi, S.;
Fujie, N.; Tanaka, M.; Sugahara, K.; Oshita, K.; Murata, M.
Thienotriazolodiazepine Compound and a Medicinal Use Thereof.
PCT/JP2006/310709 (WO/2006/129623), 2006.
(20) Miyoshi, S.; Ooike, S.; Iwata, K.; Hikawa, H.; Sugahara, K.
Antitumor Agent. PCT/JP2008/073864 (WO/2009/084693), 2009.
(21) Chung, C.-W.; Coste, H.; White, J. H.; Mirguet, O.; Wilde, J.;
Gosmini, R. L.; Delves, C.; Magny, S. M.; Woodward, R.; Hughes, S.
A.; Boursier, E. V.; Flynn, H.; Bouillot, A. M.; Bamborough, P.; Brusq,
J.-M. G.; Gellibert, F. J.; Jones, E. J.; Riou, A. M.; Homes, P.; Martin, S.
(34) Salonen, L. M.; Holland, M. C.; Kaib, P. S. J.; Haap, W.; Benz, J.;
Mary, J.-L.; Kuster, O.; Schweizer, W. B.; Banner, D. W.; Diederich, F.
Molecular recognition at the active site of factor Xa: cation−π
interactions, stacking on planar peptide surfaces, and replacement of
structural water. Chem.Eur. J. 2012, 18, 213−222.
(35) Zuber, J.; Shi, J.; Wang, E.; Rappaport, A. R.; Herrmann, H.;
Sison, E. A.; Magoon, D.; Qi, J.; Blatt, K.; Wunderlich, M.; Taylor, M.
J.; Johns, C.; Chicas, A.; Mulloy, J. C.; Kogan, S. C.; Brown, P.; Valent,
P.; Bradner, J. E.; Lowe, S. W.; Vakoc, C. R. RNAi screen identifies
Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 2011,
478, 524−528.
́
L.; Uings, I. J.; Toum, J.; Clement, C. A.; Boullay, A.-B.; Grimley, R. L.;
Blandel, F. M.; Prinjha, R. K.; Lee, K.; Kirilovsky, J.; Nicodeme, E.
Discovery and characterization of small molecule inhibitors of the BET
family bromodomains. J. Med. Chem. 2011, 54, 3827−3838.
(22) Filippakopoulos, P.; Picaud, S.; Fedorov, O.; Keller, M.; Wrobel,
M.; Morgenstern, O.; Bracher, F.; Knapp, S. Benzodiazepines and
benzotriazepines as protein interaction inhibitors targeting bromodo-
mains of the BET family. Bioorg. Med. Chem. 2012, 20, 1878−1886.
(23) Zhang, G.; Liu, R.; Zhong, Y.; Plotnikov, A. N.; Zhang, W.;
Zeng, L.; Rusinova, E.; Gerona-Nevarro, G.; Moshkina, N.; Joshua, J.;
Chuang, P. Y.; Ohlmeyer, M.; He, J. C.; Zhou, M.-M. Down-regulation
of NF-κB transcriptional activity in HIV-associated kidney disease by
BRD4 inhibition. J. Biol. Chem. 2012, 287, 28840−28851.
(36) Mertz, J. A.; Conery, A. R.; Bryant, B. M.; Sandy, P.;
Balasubramanian, S.; Mele, D. A.; Bergeron, L.; Sims, R. J. Targeting
MYC dependence in cancer by inhibiting BET bromodomains. Proc.
Natl. Acad. Sci. U.S.A. 2011, 108, 16669−16674.
(37) Delmore, J. E.; Issa, G. C.; Lemieux, M. E.; Rahl, P. B.; Shi, J.;
Jacobs, H. M.; Kastritis, E.; Gilpatrick, T.; Paranal, R. M.; Qi, J.; Chesi,
M.; Schinzel, A. C.; McKeown, M. R.; Heffernan, T. P.; Vakoc, C. R.;
Bergsagel, P. L.; Ghobrial, I. M.; Richardson, P. G.; Young, R. A.;
Hahn, W. C.; Anderson, K. C.; Kung, A. L.; Bradner, J. E.; Mitsiades,
C. S. BET bromodomain inhibition as a therapeutic strategy to target
c-Myc. Cell 2011, 146, 904−917.
(24) Hewings, D. S.; Wang, M.; Philpott, M.; Fedorov, O.; Uttarkar,
S.; Filippakopoulos, P.; Picaud, S.; Vuppusetty, C.; Marsden, B.;
Knapp, S.; Conway, S. J.; Heightman, T. D. 3,5-Dimethylisoxazoles act
as acetyl-lysine-mimetic bromodomain ligands. J. Med. Chem. 2011, 54,
6761−6770.
(38) Srivastava, V.; Tandon, A.; Ray, S. Convenient and selective
acetylations of phenols, amines and alcohols. Synth. Commun. 1992,
22, 2703−2710.
(25) Dawson, M. A.; Prinjha, R. K.; Dittmann, A.; Giotopoulos, G.;
Bantscheff, M.; Chan, W.-I.; Robson, S. C.; Chung, C.-W.; Hopf, C.;
3227
dx.doi.org/10.1021/jm301588r | J. Med. Chem. 2013, 56, 3217−3227